| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC0986 |
| Trial ID | ChiCTR2200058605 |
| Disease | Leukemia | Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Single-arm, Open-label, Single-center Clinical Study: Safety and Efficacy of Anti-CD7 CAR-T in the Treatment of Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Hebei Yanda Lu Daopei Hospital |
| Cohort 1 | |||||||
|
|||||||